… Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic
chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT). Circulation (2002) 106(…

… Chronic kidney disease (CKD) is highly prevalent in patients with chronic heart failure (CHF…
optimization of standard pharmacologic therapy for heart failure. Therefore, other treatment …

… therapy for heart failure. Val-HeFT … for chronic heart failure plus either valsartan or placebo.
Eligible patients had a history of New York Heart Association (NYHA) class II to IV heart failure…

… The treatment of chronic heart failure with reduced LVEF (HFrEF… valsartan (LCZ696), the
first compound in this new class, had a substantially lower rate of hospitalization for heart failure …

… ) for the treatment of individuals with chronic heart failure and reduced-ejection fraction (…
/valsartan with enalapril in chronic heart failure patients with HFrEF and New York-Heart As…

… progression in ACHD heart failure management would be … novel pathway in the ACHD heart
failure population. The aim of … sacubitril-valsartan use in ACHD patients with chronic NYHA …

The comparison of treatment effect and co-morbidity between the genders in the Valsartan
Heart Failure Trial showed equal benefit of treatment in men and women. Co-morbidities, …

… Given the limited evidence of the impact of sacubitril/valsartan treatment on the … chronic
heart failure, we conducted a retrospective analysis in patients treated with sacubitril/valsartan at …

… of sudden death in patients with heart failure (HF) and reduced … inhibitor sacubitril/valsartan
induces favorable ventricular … We investigated the impact of sacubitril/valsartan initiation on …

… Sacubitril/valsartan is a first-in-class angiotensin receptor-… mortality in patients with chronic,
symptomatic heart failure (HF) … the implementation of sacubitril/valsartan in clinical practice, …